getting to the heart of cancer cures
Kinnate Biopharma is driven by the urgency of cancer patients who need more effective therapies. By using next-generation genomic, molecular, and medicinal chemistry tools, they have built a best-in-class and first-in-class portfolio of kinase inhibitors targeting hard-to-treat, genetically defined cancers.
We were tasked with helping them communicate that vision to the investment and science worlds to attract critical capital and talent.
The reverse arrow in the identity represents Kinnate’s approach of working backwards from genetic markers to find the source of the cancers they will treat with targeted therapeutics.
We wanted the site to bring users into the inner world of Kinnate’s exploratory cancer science. We developed a series of videos that bring to life the various tumors and chromosomic markers that they focus on.
Visit Kinnate Biopharma
GL created a series of presentation tools and templates for the executive team to rapidly iterate and present their evolving story to investors and the scientific community.
We had a lot for fun with the leadership team, capturing their personalities through a series of headshots.
Next Case Study